Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT01238367
Eligibility Criteria:
Inclusion Criteria:
* Japanese subjects who have completed NN7008-3543
* No detectable inhibitors to factor VIII
Exclusion Criteria:
* Congenital or acquired coagulation disorders other than haemophilia A
* Planned surgery during the trial period
* Receipt of any investigational drug other than recombinant factor VIII (N8) within 30 days of trial product administration
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
12 Years
Maximum Age:
66 Years
Study:
NCT01238367
Study Brief:
Protocol Section:
NCT01238367